14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

BiondVax Pharmaceuticals Ltd. Stock Forecast


$1.30 (0%)

Volume: 21.264k

Closed: May 23, 2022

Hollow Logo Score: -1.801

BiondVax Pharmaceuticals Ltd. Stock Forecast

$1.30 (0%)

Volume: 21.264k

Closed: May 23, 2022

Score Hollow Logo -1.801

BiondVax Pharmaceuticals Ltd. Company Profile

Weizmann Science Park

Ness Ziona 7403618

972 8 930 2529


Industry: Biotechnology

Sector: Healthcare

BiondVax Pharmaceuticals Ltd.


Biondvax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel. The company offers M-001, a synthetic peptide-based protein, which is in Phase 2 clinical development stage targeting seasonal and pandemic strains of the influenza virus. Biondvax Pharmaceuticals Ltd. was founded in 2003 and is based in Ness Ziona, Israel.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE